Larson Financial Group LLC Abb Vie Inc. Transaction History

Larson Financial Group LLC

$1.75 Billion
Q3 2024

A detailed history of Larson Financial Group LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Larson Financial Group LLC holds 18,812 shares of ABBV stock, worth $3.31 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares

18,812

Previous 16,132 16.61%

Holding current value

$3.31 Million

Previous $2.77 Million 34.27%

% of portfolio

0.21%

Previous 0.19%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$163.84 - $199.33 $439,091 - $534,204	2,680 Added 16.61%	18,812 $3.71 Million
Q2 2024 Aug 02, 2024	BUY	$154.79 - $180.76 $1.67 Million - $1.95 Million	10,792 Added 202.1%	16,132 $2.77 Million
Q1 2024 May 03, 2024	BUY	$159.82 - $182.1 $400,349 - $456,160	2,505 Added 88.36%	5,340 $972,000
Q4 2023 Feb 01, 2024	BUY	$137.6 - $154.97 $41,968 - $47,265	305 Added 12.06%	2,835 $439,000
Q3 2023 Nov 03, 2023	BUY	$133.59 - $154.65 $71,604 - $82,892	536 Added 26.88%	2,530 $377,000
Q2 2023 Aug 03, 2023	SELL	$132.51 - $164.9 $2,517 - $3,133	-19 Reduced 0.94%	1,994 $268,000
Q1 2023 May 04, 2023	BUY	$144.61 - $166.54 $35,140 - $40,469	243 Added 13.73%	2,013 $320,000
Q4 2022 Feb 03, 2023	BUY	$138.31 - $165.87 $2,212 - $2,653	16 Added 0.91%	1,770 $286,000
Q3 2022 Nov 03, 2022	SELL	$134.21 - $153.93 $407,595 - $467,485	-3,037 Reduced 63.39%	1,754 $235,000
Q2 2022 Aug 04, 2022	SELL	$137.62 - $174.96 $65,782 - $83,630	-478 Reduced 9.07%	4,791 $734,000
Q1 2022 May 05, 2022	SELL	$131.98 - $163.75 $21,248 - $26,363	-161 Reduced 2.97%	5,269 $854,000
Q4 2021 Feb 03, 2022	SELL	$107.43 - $135.93 $34,162 - $43,225	-318 Reduced 5.53%	5,430 $735,000
Q3 2021 Nov 04, 2021	BUY	$106.4 - $120.78 $541,044 - $614,166	5,085 Added 766.97%	5,748 $620,000
Q2 2021 Aug 10, 2021	BUY	$105.21 - $117.21 $736 - $820	7 Added 1.07%	663 $75,000
Q1 2021 May 06, 2021	BUY	$102.3 - $112.62 $2,250 - $2,477	22 Added 3.47%	656 $71,000
Q4 2020 Jan 14, 2021	BUY	$80.49 - $108.67 $563 - $760	7 Added 1.12%	634 $68,000
Q3 2020 Oct 08, 2020	SELL	$85.91 - $100.83 $945 - $1,109	-11 Reduced 1.72%	627 $55,000
Q2 2020 Jul 10, 2020	BUY	$73.37 - $98.18 $16,875 - $22,581	230 Added 56.37%	638 $63,000
Q1 2020 Apr 09, 2020	SELL	$64.5 - $97.79 $709 - $1,075	-11 Reduced 2.63%	408 $31,000
Q4 2019 Jan 10, 2020	SELL	$72.13 - $90.25 $20,412 - $25,540	-283 Reduced 40.31%	419 $37,000
Q3 2019 Oct 11, 2019	BUY	$62.98 - $75.72 $14,422 - $17,339	229 Added 48.41%	702 $53,000
Q2 2019 Jul 16, 2019	BUY	$65.7 - $83.98 $4,664 - $5,962	71 Added 17.66%	473 $34,000
Q1 2019 Apr 05, 2019	BUY	$77.14 - $90.79 $385 - $453	5 Added 1.26%	402 $32,000
Q4 2018 Feb 07, 2019	BUY	$77.85 - $96.01 $30,906 - $38,115	397 New	397 $37,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $312B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Larson Financial Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Larson Financial Group LLC with notifications on news.

Account

Larson Financial Group LLC Abb Vie Inc. Transaction History